We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

1 hedge funds and large institutions have $0 invested in Arena Pharmaceuticals Inc in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 312 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 316 → 1 (-315)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

100% less capital invested

Capital invested by funds: $4.86B → $0 (-$4.86B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 312

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-315
Holders Change %
-99.68%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
312
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$530M
2
BlackRock
BlackRock
New York
-$452M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$361M
4
State Street
State Street
Massachusetts
-$213M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$167M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
51
D.E. Shaw & Co
New York
– -$21.2M -228,325 Closed
WCMNY
52
Westchester Capital Management (New York)
New York
– -$20.9M -224,444 Closed
WP
53
Woodline Partners
California
– -$19.5M -210,337 Closed
Alyeska Investment Group
54
Alyeska Investment Group
Illinois
– -$18.6M -200,000 Closed
YCM
55
Yiheng Capital Management
California
– -$18M -193,195 Closed
Susquehanna International Group
56
Susquehanna International Group
Pennsylvania
– -$17.7M -190,490 Closed
Renaissance Technologies
57
Renaissance Technologies
New York
– -$16.9M -181,516 Closed
TCM
58
Tekla Capital Management
Massachusetts
– -$16.4M -175,976 Closed
American Century Companies
59
American Century Companies
Missouri
– -$16.1M -173,084 Closed
RA
60
Ramius Advisors
New York
– -$15M -161,770 Closed
Morgan Stanley
61
Morgan Stanley
New York
– -$14.8M -159,095 Closed
Barclays
62
Barclays
United Kingdom
– -$13.9M -149,859 Closed
UBS AM
63
UBS AM
Illinois
– -$13.9M -149,452 Closed
Man Group
64
Man Group
United Kingdom
– -$13.7M -147,637 Closed
MP
65
Mangrove Partners
Connecticut
– -$13.5M -145,087 Closed
WIC
66
Water Island Capital
New York
– -$13.1M -140,800 Closed
EA
67
Emerald Advisers
Pennsylvania
– -$13M -139,997 Closed
Russell Investments Group
68
Russell Investments Group
United Kingdom
– -$12.8M -137,993 Closed
Verition Fund Management
69
Verition Fund Management
Connecticut
– -$12.3M -132,701 Closed
PCM
70
Pentwater Capital Management
Florida
– -$12.1M -130,000 Closed
Swiss National Bank
71
Swiss National Bank
Switzerland
– -$11.9M -127,705 Closed
Assenagon Asset Management
72
Assenagon Asset Management
Luxembourg
– -$11.7M -126,106 Closed
JG
73
Jefferies Group
New York
– -$11.3M -121,719 Closed
DCM
74
Driehaus Capital Management
Illinois
– -$11.3M -121,698 Closed
PCM
75
Peregrine Capital Management
Minnesota
– -$11.2M -119,983 Closed
1 2
3
4 5

ARNA Hedge Fund Activity: Q1 2022 in Review

1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2022, worth a combined $0 — down 100% from $4.86B a quarter earlier.

Sellers outnumbered buyers: 312 funds closed out of ARNA and 0 opened new positions — a net loss of 312 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $530M sold.

  • 1 institutional investor held Arena Pharmaceuticals Inc (ARNA) as of Q1 2022, down from 316 in Q4 2021.
  • Funds reported $0 of Arena Pharmaceuticals Inc stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Arena Pharmaceuticals Inc positions in Q1 2022 and 312 closed out, a net change of -312 holders.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2022 was Vanguard Group, an estimated $530M sold.

Based on aggregated 13F filings for Q1 2022.